Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Deloitte
Moodys
Boehringer Ingelheim
Novartis
McKinsey
Merck
Fish and Richardson
Mallinckrodt
UBS

Generated: January 21, 2018

DrugPatentWatch Database Preview

INDAPAMIDE Drug Profile

« Back to Dashboard

Drug patent expirations by year for INDAPAMIDE
Pharmacology for INDAPAMIDE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for INDAPAMIDE

US Patents and Regulatory Information for INDAPAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth INDAPAMIDE indapamide TABLET;ORAL 074722-001 Jun 17, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs INDAPAMIDE indapamide TABLET;ORAL 074585-002 Sep 26, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc INDAPAMIDE indapamide TABLET;ORAL 074299-001 Jul 27, 1995 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amerigen Pharms Ltd INDAPAMIDE indapamide TABLET;ORAL 075201-002 Dec 4, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc INDAPAMIDE indapamide TABLET;ORAL 075105-002 Jul 23, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc INDAPAMIDE indapamide TABLET;ORAL 074498-001 Oct 31, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva INDAPAMIDE indapamide TABLET;ORAL 074665-002 Apr 4, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz INDAPAMIDE indapamide TABLET;ORAL 074594-002 May 23, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth INDAPAMIDE indapamide TABLET;ORAL 074722-002 Jun 17, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amerigen Pharms Ltd INDAPAMIDE indapamide TABLET;ORAL 075201-001 Dec 4, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Teva
Harvard Business School
Moodys
Boehringer Ingelheim
Express Scripts
Dow
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot